IPIRA Startups

IPIRA Startups

Oncobionic

Brief Description

Oncobionic commercialized irreversible electroporation (IRE) technology, a minimally invasive treatment for tumors that revolutionized cancer therapy. The minimally invasive surgical system delivers 1,500 volts of electric current through needle-like probes, ablating the targeted area, making it possible to remove unresectable tumors near critical structures and major blood vessels without cuts or incisions. IRE exclusively targets the tumor’s cell membranes, leaving critical organs, vasculature, ducts and nerves completely unharmed.

The IRE...

Libraria, Inc.

Brief Description

Libraria Inc. is using computational techniques to discover new small-molecule drugs that can be administered orally. Its proprietary technology enables the company and its partners to leverage known molecular structures, chemistry protocols, and bioactivity data to speed the chemistry phase of drug discovery by up to 50%.

Timeline

2000. Company founded.

2003. Acquired by Eidogon-Sertanty.

Inventors Jonathan Ellman

IntegenX

Brief Description

IntegenX is the market leader of Rapid DNA technology for human identification in forensics and law enforcement applications. IntegenX’s RapidHIT technologies integrate advanced fluidics, optics, and biochemistry capabilities to produce sample-to-answer solutions for DNA-based human identity testing. The RapidHIT ID System for Crime Labs generates lab-...

Inktomi Corporation

Brief Description

Inktomi's core technology was born out of US DARPA funded research on massively paralleled systems. The company's original focus was on large scale Internet search, providing private-labeled search services to some of the world's best known search engines including Yahoo!, Microsoft, AOL, and others. Inktomi later introduced high-end network cacheing software, sold primarily to telecom and internet service providers, to dramatically improve the performance of web-based network traffic.

The company was co-founded by UC Berkeley Computer Science Professor Eric...

Fluxion Biosciences, Inc.

Brief Description

Fluxion Biosciences provides analytical, live cell analysis tools that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms in physiologically relevant micro-environments, Fluxion helps bridge the translational medicine gap by bringing research data closer to patients. Fluxion's innovative systems for live cell analysis are enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.

Timeline 2005. Company founded...

Iris Micromedical, Inc.

Brief Description

Drug delivery based on microstructural devices that administer therapeutic agents to selected target sites for treatment.

Iris Micromedical was focused on the development of UC Berkeley Associate Professor of Engineering Mauro Ferrari's silicon particulate technology for the intravascular targeted treatment of cancer imedd.

Four years after founding Iris Micromedical, Dr. Ferrari moved to Ohio State University as a professor of bioengineering, internal medicine, and mechanical engineering, and reformed the company as IMedd, Inc.

Timeline 1995....

Iota Biosciences

Brief Description

Established in 2017, iota Biosciences was formed with a vision to change how the world monitors and treats disease. Building on award-winning 'neural dust' technology invented at the University of California, Berkeley, we are building a platform for the future of bioelectronic medicine.

Timeline 2017. Company founded. Inventors

Michel Maharbiz, Jose Carmena

CalGen Therapeutics

Brief Description

Developer of a therapeutic inhaled antisense technology designed to prevent and treat respiratory infections.

Timeline 2021. Company founded Inventors

Kasper Karstensen, Sakari Kauppinen, Anders Michael Naar, Chi Zhu

Biotock

Brief Description

Development of treatments for age-related macular degeneration, a leading cause of blindness.

Timeline 2022. Company founded Inventors

Monika Maria Haoui, Polina Lishko

BioScale, Inc.

Brief Description

BioScale developed diagnostic solutions that address critical unmet needs in population health and chronic care. An area of focus has been vulnerable populations such as those with chronic obstructive pulmonary disease, diabetes, and cardiovascular disease. The company's algorithms utilized combinations of blood-based biomarkers for identifying individuals at high risk for severe outcomes. BioScale's rigorous approach to test development included collaborating with leading academic medical centers and validating assays in large, carefully curated cohorts.

Bioscale...